The identification of the hsa-miR-659-3p/RON and RON/JNK/HIF-2α/MMP12 pathways offer valuable insights into the pathogenesis of bladder cancer and may serve as potential targets for therapeutic interventions in the management of this disease. This evidence concerns the gene MMP12 and urinary bladder cancer.